1. Home
  2. ONL vs NERV Comparison

ONL vs NERV Comparison

Compare ONL & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion Office REIT Inc.

ONL

Orion Office REIT Inc.

HOLD

Current Price

$2.19

Market Cap

165.4M

Sector

Real Estate

ML Signal

HOLD

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$2.30

Market Cap

166.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONL
NERV
Founded
2021
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
165.4M
166.4M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
ONL
NERV
Price
$2.19
$2.30
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $10.33
AVG Volume (30 Days)
★ 333.0K
105.4K
Earning Date
11-05-2026
11-04-2026
Dividend Yield
★ 3.72%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.19
N/A
Revenue
★ $147,647,000.00
$41,175,600.00
Revenue This Year
$1.67
N/A
Revenue Next Year
$0.11
N/A
P/E Ratio
$11.21
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.89
$2.24
52 Week High
$3.05
$8.80

Technical Indicators

Market Signals
Indicator
ONL
NERV
Relative Strength Index (RSI) 42.49 27.35
Support Level $1.91 N/A
Resistance Level $2.59 $5.69
Average True Range (ATR) 0.08 0.26
MACD 0.01 -0.02
Stochastic Oscillator 52.75 4.83

Price Performance

Historical Comparison
ONL
NERV

About ONL Orion Office REIT Inc.

Orion Properties Inc is an internally managed real estate investment trust engaged in the ownership, acquisition, and management of a diversified portfolio of office properties located in high-quality suburban markets across the United States and leased mainly on a single-tenant net lease basis to creditworthy tenants. Its portfolio is comprised of traditional office properties, as well as governmental, medical office, flex/laboratory, and R&D and flex/industrial properties. The company is focused on shifting its portfolio concentration over time away from traditional office properties, towards more dedicated use assets with specialized uses that include an office component. It operates in one business segment: commercial real estate.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: